Clinical Trial Update: An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain [Phase 4]

View source ↗

Summary

Open-label Phase 4 study assessing safety and effectiveness of hydromorphone oral solution for postoperative pain in pediatric patients aged 28 days to 16 years…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• hydromorphone oral solution (hydromorphone)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Postoperative Pain | Phase 4 | Status: COMPLETED | Results posted: 2011-03-11